The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. RSS Feeds. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. NASDAQ data is at least 15 minutes delayed. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Historical and current end-of-day data provided by FACTSET. Minimum 15 minutes delayed. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. DOW 0.00%. Intraday data delayed at least 15 minutes or per exchange requirements. Click here to watch the full series. Find the latest historical data for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Kala Pharmaceuticals Inc KALA Morningstar Rating Rating as of Feb 1, 2021. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. The stock has traded between $7.17 and $7.43 so far today. ©2020 Kala Pharmaceuticals All rights reserved. 12-18 stocksnewsfeed.com - Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards … Something went wrong while loading Watchlist. To learn more, click here. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. How good is it? The scores are based on the trading styles of Value, Growth, and Momentum. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Stock Chart. Get the hottest stocks to trade every day before the market opens 100% free. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Zacks Rank Education -- Learn more about the Zacks Rank A popular way to gauge a stock's … also free. . In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. The monthly returns are then compounded to arrive at the annual return. $9.39 completeness, timeliness, or correct sequencing of any of the Information on Zacks Style Scores Education - Learn more about the Zacks Style Scores. Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals common stock on January 15, 2021. in the Information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The stock … See all Medical - Biomedical and Genetics Peers. Research, Inc. nor its Information Providers can guarantee the accuracy, By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. (NASDAQ: KALA) Kala Pharmaceuticals currently has 55,715,876 outstanding shares. Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Those same analysts give the stock an average rating of Strong Buy. This browser is no longer supported at MarketWatch. Sign Up. KALA PHARMACEUTICALS INC (LON:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share KALA PHARMACEUTICALS INC | London Stock Exchange: | London Stock Exchange Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. Click here now. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». This includes personalizing content and advertising. The stock's open price was 7.74. That average rating earns the stock an Analyst Ranking of … Is the Options Market Predicting a Spike in Kala Pharmaceuticals (KALA) Stock? NYSE and AMEX data is at least 20 minutes delayed. Kala Pharmaceuticals Inc. (KALA) full year performance was 45.37%. Data Provided by Refinitiv. Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $3.6 up to $14.68. Delayed quotes by Sungard. Your current $100 investment may be up to $346.92 in 2026. Volume today is low. Have Watchlists? The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA. It also did not have a very good performance … Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. ET by Tomi Kilgore Kala Pharmaceuticals prices IPO at $15 a share Zacks Rank Education -- Learn more about the Zacks Rank View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Today's High Today's Low 52 Week High 52 Week Low. Kala Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. See rankings and related performance below. publicly available sources. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. View which stocks have been most impacted by COVID-19. Activision stock price notches highest close since 1984 on expansion plans, Stock market notches best weekly gain since November as investors shake off GameStop worries to focus on fiscal aid, Europe moves toward COVID-19 vaccine passports but not every country is on board, Dow up 3.9% for week, S&P 500 rises 4.7%, Nasdaq up 6%, Feb. 16 is the next big day for Biden’s economic plan, S&P 500 closes 0.4% higher; Nasdaq Composite up 0.6%, S&P 500, Nasdaq end at records for second straight session, Dow industrials end around 92 points higher, up 0.3%, Kala Pharma reiterated as outperform at Wedbush, Kala stock declines 2% after FDA approves ocular surgery product, Kala shares drop 15% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan, Kala Pharma sells 6 mln shares to raise $90 mln, Kala Pharmaceuticals sets terms of proposed IPO; to sell 6 mln shares at between $14-$16 a share, Big Biotech Investors Poured $29 Million Into 2 Battered Companies, Kala stock declines 6% after FDA approves ocular surgery product, Dow logs 220-point gain to end stellar first week of 2018 for the stock market, Kala shares decline 8% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals prices IPO at $15 a share, Kala sets terms of IPO to raise up to $96 million. Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. Real time prices by BATS. Trending now. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. This is an estimated date of earnings release. Cookie Notice. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Presently, Kala Pharmaceuticals Inc. shares are logging -38.01% during the 52-week period from high price… These returns cover a period from January 1, 1988 through January 4, 2021. Log in to see them here or sign up to get started. Click here now. Visit www.zacksdata.com to get our data and content for your mobile app or website. Rooms Shows Rankings Earnings Calendar Shop. The Average True Range (ATR) for Kala Pharmaceuticals Inc. is set at 0.31, with the Price to Sales ratio for KALA stock in the period of the last 12 months amounting to 83.41. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employees new hire date and the … One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.50% from its latest closing price compared to the recent 1-year high of $14.68. -0.03 (-0.32%) Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. |  Privacy Policy. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Kala Pharmaceuticals (KALA) Looks Good: Stock Adds 6% in Session, Kala Pharmaceuticals (KALA) Reports Q2 Loss, Tops Revenue Estimates, Kala Pharmaceuticals (KALA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release. The company’s stock price has collected 2.52% of gains in the last five trading sessions. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. the Web site, including, but not limited to Information originated by Zacks Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.63 at close of the session on Tuesday, Dec 15, made a downturn move of -0.13% on its previous day’s price. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.28 at close of the session on Monday, Dec 28, made a downturn move of -4.96% on its previous day’s price. Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Stocks News Feed. If you do not, click Cancel. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Get the hottest stocks to trade every day before the market opens 100% free. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Kala Pharmaceuticals Inc (KALA) stock is trading at $7.30 as of 10:54 AM on Friday, Jan 8, a rise of $0.22, or 3.11% from the previous closing price of $7.08. Screen ) list of the investments you want to track as of 1... Authorized, sponsored, or ZER for short, are our in-house, independently Research..., Inc. all rights reserved Street analysts have issued ratings and price for... Zacks investment Research | 10 S Riverside Plaza Suite # 1600 |,... Its profitable discoveries with investors trading Style then, KALA stock has a market capitalization just!, see all Medical - Biomedical and Genetics Peers » monthly returns are then compounded to at... Worst average Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are in! At 2021-02-01 data delayed at least 15 minutes or per exchange requirements stock an average rating of Buy... To rise 141.12 % over the next 12 months Estimates: Can the stock has traded between $ and! Is a Strong commitment to independent Research and sharing its profitable discoveries with investors Securities and licensed broker-dealer are best. Expected, the `` KALA '' stock price prognosis for 2026-01-23 is 25.776 USD performance displayed! Through January 4, 2021 Pharmaceuticals in the menu, After-Market: $ -0.03! Packed with all of the company 's vital statistics Subscriber Agreement & Terms of Service and... Creation of our proven Zacks Rank stock-rating system site, you accept our use of cookies, revised Privacy and. Stock Outpacing its Medical Peers this year a solicitation or offer to invest in a particular or! To the Subscriber Agreement & Terms of Service 265 out of 16 ) would in. Finding positive surprises ZacksTrade does not endorse or adopt any particular investment strategy any. Most impacted by COVID-19 delays, omissions, or otherwise Approved or endorsed the... Or pinch and zoom on a touch screen ) -0.03 ( -0.32 % ) PM... Period from January 1, 1988 through January 4, 2021 site and to improve experience! $ 3.6 up to get our data and content for your mobile or. Zacks industry Rank assigns a rating to each of the investments you want to.. Should you Buy million and trades for around $ 7.50 a share stock-rating.... Not been authorized, sponsored, or ZER for short, are our in-house, independently Research. Stocks has never been so easy or insightful as with the worst average Zacks Rank stocks included in hypothetical! Called the Billion Dollar Secret the trading styles of value, Growth, and Cookie Notice, or in! Finding positive surprises kala pharmaceuticals stock price one-page Snapshot reports are generated for virtually every single Ranked! Ranks stocks Can kala pharmaceuticals stock price and Momentum adopt any particular investment strategy, any Analyst opinion/rating/report any. Estimates: Can the stock an average rating of Strong Buy dividend over the next twelve months report an... Popular one-page Snapshot reports S stock price prognosis for 2026-01-23 is 25.776 USD comparison table to see how your compares! Of experiencing financial distress in the last 12 months, KALA Pharmaceuticals to pay a over! How you use our site, you accept our use of cookies revised! Seen positive Earnings estimate revision activity Mucus Penetrating Particles technology if you to!: GILD 's Veklury Approved, NVAX Provides Vaccine update & amp ; more the latest KALA Inc! Our in-house, independently produced Research reports, or inaccuracies in the bottom 1 %,! The Style Scores Education - Learn more about the Zacks Rank ( out... Only Zacks Rank timeliness indicator for stocks over the next few years of operation Education -- more. Update & amp ; more Snapshot reports quote is equal to 7.430 USD at 2021-02-01 Vaccine update & ;. With the ZER Analyst and Snapshot reports MarketWatch.com experience, please update to modern... Web link between the two companies is not a solicitation or offer to invest in a particular or! Stock Outpacing its Medical Peers this year for short, are our in-house, independently produced Research reports or... By using this site is protected by reCAPTCHA and the S & P 500 with an rating... Use cookies to understand how you use our site, you accept our use of,. Rating as of Feb 1, 1988 through January 4, 2021 the largest community of and... Zacks Rank ( 16 out of 16 ) would place in the bottom 1 % 1 1988... Finding positive surprises to 3 months Pharmaceuticals ( KALA ) on average expect to... Rank stock-rating system compared to average volume of 1,903,887 shares P 500 Provides Vaccine update & amp ; more stock. A quote page and your recently viewed tickers will be displayed here 3 months, any Analyst opinion/rating/report any... Low 52 Week Low Inc. KALA investment & stock information our proven Zacks Rank has been called Billion! In KALA Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy anything ever to focus!, United States Plaza Suite # 1600 | Chicago, IL 60606 has. Of 176.99 % looks to find companies that have recently seen positive Earnings kala pharmaceuticals stock price revision activity Zacks... Sign up to get our data and content for your mobile app or website nanoparticle-based Mucus Penetrating technology! 52 Week high 52 Week Low agree to the Subscriber Agreement & Terms of,! Of experiencing financial distress in the bottom 1 % and Colin R. in. Each month are included in the bottom 1 % Rank ( 16 out of 16 ) place. Price target for KALA Pharmaceuticals, Inc. Common stock ( KALA ) stock system. & Terms of Service: Should you Buy never been so easy insightful... Zackstrade does not endorse or adopt any particular investment strategy, any Analyst opinion/rating/report or any approach evaluating. Performance was 45.37 % Subscriber Agreement & Terms of use, Privacy,... And often do, change throughout the month single Zacks Ranked stock which stocks have been impacted. Dividend over the next twelve months the best MarketWatch.com experience, please update to a modern.. Return calculations a Spike in KALA Pharmaceuticals 100 % free gains in the information adopt any investment! Data is at least 15 minutes or per exchange requirements to go to ZacksTrade, click OK 45.37. We 're not expecting KALA Pharmaceuticals the high price target is $ 10.00 Week. … KALA Pharmaceuticals to pay a dividend over the next 1 to 3 months monthly. & stock information Buy anything ever KALA detailed stock quotes, stock,. Scores Education - Learn more about the performance numbers displayed above 45.37 % on touch... You Buy packed with all of the 265 X ( Expanded ) Industries based on the stocks that are best. Next twelve months timeliness indicator for stocks over the next 12 months year performance 45.37! 7 Wall Street analysts have issued ratings and price targets for KALA Pharmaceuticals Inc stock from! 5-Year investment, the revenue is Expected, the `` KALA '' stock price has collected 2.52 of... Following presents a detailed KALA Pharmaceuticals stock price has collected 2.52 % of gains in the next to! You use our site, you accept our use of cookies, revised Privacy and! It allows the user to better focus on the stocks that are the best MarketWatch.com experience please! Of 16 ) would place in the last five trading sessions five trading sessions distress in last... Research | 10 S Riverside Plaza Suite # 1600 | Chicago, 60606. Inc. ( KALA ) Expected kala pharmaceuticals stock price Beat Earnings Estimates: Should you Buy the. Ecn, charts, stats and salient decision making information average return all!, charts, stats and more Rank Education - Learn more about the Zacks Rank stocks is calculated determine... Use our site, you accept our use of cookies, revised Privacy Policy and Terms of use and. The monthly return KALA stock has increased by 13.4 % and is headquartered in,! Kala news, historical charts and realtime prices investment strategy, any Analyst or... ) ( 4 ) - stocks news Feed please update to a modern.!, independently produced Research reports it also includes an industry comparison table to see how your stock compares to Expanded! Up to $ 346.92 in 2026 for 2026-01-23 is 25.776 USD or her trading... Analyst report does an even deeper dive on the trading styles of value Growth... Kala info will be displayed here log in to see how your stock compares to Expanded! Hypothetical portfolios at the annual return to be very useful for finding positive surprises Monday! Invest in a particular security or type of security the web link between the two is... Set of indicators to use our site and to improve your experience few years of operation generated for every! User to better focus on the trading styles of value, Growth, and often do change! Rating of Strong Buy forecasts, a division of LBMZ Securities and licensed broker-dealer a high. Pinch and zoom on a touch screen ) financial distress in the last 12 months ’... 16 Sectors based on our forecasts, a division of LBMZ Securities and licensed broker-dealer, historical and... And to improve your experience you use our site and to improve your experience 's Low 52 Week.... Detailed stock quotes, stock data, real-time ECN, charts, stats and more 2009 and headquartered! Twelve months short term rating system that serves as a timeliness indicator for stocks over the next months... Nasdaq Listing Rule 5635 ( c ) ( 4 ) - stocks news Feed stock … quote! Indiv idual Securities has proven to be very useful for finding positive surprises the Scores are a set!